# Abbott Net Income

ABT | Stock | ## USD 111.90 0.42 0.38% |

Abbott Laboratories fundamentals help investors to digest information that contributes to Abbott Laboratories' financial success or failures. It also enables traders to predict the movement of Abbott Stock. The fundamental analysis module provides a way to measure Abbott Laboratories' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abbott Laboratories stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Abbott | Net Income |

**B**in 2022. Net Income Common Stock is likely to drop to about 5.8

**B**in 2022.

## Abbott Net Income Analysis

Abbott Laboratories' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.## Abbott Laboratories Net Income | ## 5.8 Billion |

Net Income | = | (Rev + Gain) | - | (Exp + Loss) |

## Current Abbott Laboratories Net Income | 8.53 B |

Most of Abbott Laboratories' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abbott Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

## Abbott Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Abbott Laboratories is extremely important. It helps to project a fair market value of Ford stock properly, considering its historical fundamentals such as Net Income. Since Abbott Laboratories' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Abbott Laboratories' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Abbott Laboratories' interrelated accounts and indicators.

## Abbott Net Income Historical Pattern

Today, most investors in Abbott Laboratories Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Abbott Laboratories' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's net income growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Abbott Laboratories net income as a starting point in their analysis.

Abbott Laboratories Net Income |

Share

Timeline |

Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Compare to competition |

## Abbott Accumulated Other Comprehensive Income

## Accumulated Other Comprehensive Income | ## (9.04 Billion) |

Based on the recorded statements, Abbott Laboratories reported net income of 8.53

**B**. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The net income for all United States stocks is significantly lower than that of the firm.## Abbott Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abbott Laboratories' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abbott Laboratories could also be used in its relative valuation, which is a method of valuing Abbott Laboratories by comparing valuation metrics of similar companies.Abbott Laboratories is currently under evaluation in net income category among related companies.

## Abbott Laboratories Current Valuation Drivers

We derive many important indicators used in calculating different scores of Abbott Laboratories from analyzing Abbott Laboratories' financial statements. These drivers represent accounts that assess Abbott Laboratories' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Abbott Laboratories' important valuation drivers and their relationship over time.

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

Net Income Per Employee | 4.82 K | 22.99 K | 34.46 K | 41.13 K | 62.58 K | 56.09 K | |

Revenue Per Employee | 276.67 K | 296.87 K | 298.17 K | 316.64 K | 381.19 K | 391.53 K | |

Average Assets | 72.63 B | 69.53 B | 68.12 B | 69.29 B | 73.76 B | 72.94 B | |

Earnings Before Interest Taxes and Depreciation Amortization EBITDA | 6.28 B | 7.01 B | 7.76 B | 8.87 B | 12.28 B | 10.6 B | |

Earnings Before Interest Taxes and Depreciation Amortization USD | 6.28 B | 7.01 B | 7.76 B | 8.87 B | 12.28 B | 10.6 B | |

Earnings before Tax | 2.35 B | 2.91 B | 4.08 B | 4.99 B | 8.21 B | 6.71 B | |

Average Equity | 31.66 B | 31 B | 31.59 B | 31.46 B | 34.62 B | 34.04 B | |

Enterprise Value | 112.35 B | 143.22 B | 168.61 B | 208.14 B | 257.96 B | 207.34 B | |

Free Cash Flow | 4.43 B | 4.91 B | 4.5 B | 5.72 B | 8.65 B | 7.28 B | |

Invested Capital | 40.16 B | 31.45 B | 30.8 B | 33.71 B | 34.37 B | 35.08 B | |

Invested Capital Average | 38.38 B | 32.91 B | 32.55 B | 33.39 B | 33.57 B | 33.94 B | |

Market Capitalization | 99.34 B | 127.04 B | 153.61 B | 194.06 B | 248.87 B | 197.54 B | |

Tangible Asset Value | 30.76 B | 24.98 B | 27.67 B | 34.02 B | 39.23 B | 34.16 B | |

Working Capital | 11.23 B | 5.62 B | 4.8 B | 8.53 B | 11.13 B | 9.9 B |

## Abbott Laboratories ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Abbott Laboratories' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.Environment Score | Governance Score | Social Score |

## Abbott Fundamentals

Return On Equity | 22.26 % | |||

Return On Asset | 8.56 % | |||

Profit Margin | 18.78 % | |||

Operating Margin | 22.96 % | |||

Current Valuation | 199.77 B | |||

Shares Outstanding | 1.77 B | |||

Shares Owned by Insiders | 0.73 % | |||

Shares Owned by Institutions | 75.55 % | |||

Number of Shares Shorted | 14.22 M | |||

Price to Earning | 27.66 X | |||

Price to Book | 5.73 X | |||

Price to Sales | 4.33 X | |||

Revenue | 45.55 B | |||

Gross Profit | 25.01 B | |||

EBITDA | 13.83 B | |||

Net Income | 8.53 B | |||

Cash and Equivalents | 8.16 B | |||

Cash per Share | 4.66 X | |||

Total Debt | 17.12 B | |||

Debt to Equity | 0.48 % | |||

Current Ratio | 1.85 X | |||

Book Value Per Share | 19.47 X | |||

Cash Flow from Operations | 9.96 B | |||

Short Ratio | 2.64 X | |||

Earnings Per Share | 4.03 X | |||

Price to Earnings To Growth | 1.99 X | |||

Number of Employees | 113 K | |||

Beta | 0.74 | |||

Market Capitalization | 197.13 B | |||

Total Asset | 41.25 B | |||

Retained Earnings | 26.88 B | |||

Working Capital | 4.97 B | |||

Current Asset | 14.15 B | |||

Current Liabilities | 9.19 B | |||

Z Score | 7.6 | |||

Five Year Return | 1.54 % | |||

Last Dividend Paid | 1.88 |

## About Abbott Laboratories Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Abbott Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abbott Laboratories using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abbott Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Last Reported | Projected for 2022 | |

Net Income | 7.1 B | 5.8 B |

Net Income Common Stock | 7.1 B | 5.8 B |

Net Income Per Employee | 62.6 K | 56.1 K |

## Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.## Did you try this?

### Run Theme Ratings Now

## Theme RatingsDetermine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |

All Next | Launch Module |

## Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.### Moving against Abbott Laboratories

0.56 | ACXP | Acurx Pharmaceuticals | Earnings Call Today | PairCorr |

The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.

The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Please continue to Abbott Laboratories Piotroski F Score and Abbott Laboratories Altman Z Score analysis. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

## Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.

Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. | Go | |

Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | Go | |

Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets | Go | |

ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world | Go | |

Price TransformationUse Price Transformation models to analyze depth of different equity instruments across global markets | Go |

Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth YOY 0.73 | Market Capitalization 195.2 B | Quarterly Revenue Growth YOY 0.1 | Return On Assets 0.0896 | Return On Equity 0.24 |

The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.